[法布里病的酶替代疗法：一种酶的稀缺凸显生物技术的脆弱性] - Suppr

Suppr

超能文献

[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].

作者信息

Lidove Olivier, Choukroun Gabriel, Bekri Soumeya, Viot Géraldine, Tsimaratos Michel, Joly Dominique

出版信息

Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2.

DOI:10.1016/j.lpm.2010.01.002

PMID:20194001

Abstract

摘要

相似文献

[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].

Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2.

Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.

Int J Clin Pract. 2010 Jun;64(7):995. doi: 10.1111/j.1742-1241.2009.02323.x.

Clinical trial for Fabry disease faces continuing hurdles.

CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13.

Fabry disease: is there a role for enzyme replacement therapy?

J Intern Med. 2013 Oct;274(4):329-30. doi: 10.1111/joim.12089. Epub 2013 May 30.

Enzyme replacement therapy for Fabry's disease.

Lancet. 2010 May 1;375(9725):1523; author reply 1523-4. doi: 10.1016/S0140-6736(10)60653-8.

Enzyme replacement therapy for Fabry's disease.

Lancet. 2010 May 1;375(9725):1522-3; author reply 1523-4. doi: 10.1016/S0140-6736(10)60652-6.

Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?

J Eur Acad Dermatol Venereol. 2010 Jun;24(6):737-8. doi: 10.1111/j.1468-3083.2009.03455.x. Epub 2009 Nov 11.

[Utility of enzyme replacement therapy in Fabry disease].

Med Clin (Barc). 2010 Apr 3;134(9):402-5. doi: 10.1016/j.medcli.2009.07.053. Epub 2010 Feb 6.

Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.

J Am Soc Nephrol. 2018 Sep;29(9):2265-2278. doi: 10.1681/ASN.2018030329. Epub 2018 Aug 9.

March on, not in.

Nat Med. 2011 May;17(5):515. doi: 10.1038/nm0511-515.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech].

Presse Med. 2010 May;39(5):527-9. doi: 10.1016/j.lpm.2010.01.002. Epub 2010 Mar 2.

Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.

Int J Clin Pract. 2010 Jun;64(7):995. doi: 10.1111/j.1742-1241.2009.02323.x.

Clinical trial for Fabry disease faces continuing hurdles.

CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13.

Fabry disease: is there a role for enzyme replacement therapy?

J Intern Med. 2013 Oct;274(4):329-30. doi: 10.1111/joim.12089. Epub 2013 May 30.

Enzyme replacement therapy for Fabry's disease.

Lancet. 2010 May 1;375(9725):1523; author reply 1523-4. doi: 10.1016/S0140-6736(10)60653-8.

Enzyme replacement therapy for Fabry's disease.

Lancet. 2010 May 1;375(9725):1522-3; author reply 1523-4. doi: 10.1016/S0140-6736(10)60652-6.

Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?

J Eur Acad Dermatol Venereol. 2010 Jun;24(6):737-8. doi: 10.1111/j.1468-3083.2009.03455.x. Epub 2009 Nov 11.

[Utility of enzyme replacement therapy in Fabry disease].

Med Clin (Barc). 2010 Apr 3;134(9):402-5. doi: 10.1016/j.medcli.2009.07.053. Epub 2010 Feb 6.

Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.

J Am Soc Nephrol. 2018 Sep;29(9):2265-2278. doi: 10.1681/ASN.2018030329. Epub 2018 Aug 9.

March on, not in.

Nat Med. 2011 May;17(5):515. doi: 10.1038/nm0511-515.